title: Molecular alterations in oral carcinogenesis: significant risk predictors in malignant transformation and tumor progression.
abstract: In this study an attempt was made to establish the significance of a battery of molecular alterations and thereby identify risk predictors in oral carcinogenesis. For this purpose, EGFR, Stat3, H-ras, c-myc, p53, cyclin D1, p16, Rb, Ki-67 and Bcl-2 were localized immunohistochemically in normal mucosa (n=12), hyperplasia (n=35), dysplasia (n=25), early stage carcinoma (n=65) and advanced stage carcinoma (n=70). Deregulation occurred at an early stage and the number of alterations increased with disease progression. Using multivariate logistic regression analysis, the significant risk predictor for hyperplasia from normal mucosa was Ki-67 (OR=5.75, p=0.021); the significant risk predictors for dysplasia from hyperplasia were EGFR (OR=12.96, p=0.002), Stat3 (OR=17.16, p=0.0001), p16 (OR=5.50, p=0.039) and c-myc (OR=5.99, p=0.052); the significant risk predictors for early stage carcinoma from dysplasia were p53 (OR=6.63, p=0.0001) and Rb (OR=3.81, p=0.056); and the significant risk predictors for further progression were EGFR (OR=5.50, p=0.0001), Stat3 (OR=4.49, p=0.0001), H-ras (OR=4.05, p=0.001) and c-myc (OR=2.99, p=0.015). Cyclin D1 holds a key position linking upstream signaling pathways to cell cycle regulation. Gene products of the mitogenic signaling pathway play an equally significant role as cell cycle regulatory proteins in the hyperplasia-dysplasia-early-advanced-carcinoma sequence and together may provide a reference panel of markers for use in defining premalignant lesions and predicting the risk of malignant transformation and tumor progression.
authors.affiliation: Division of Molecular Endocrinology, Gujarat Cancer and Research Institute, Ahmedabad, India. dmegcri@yahoo.com
authors.forename: N G
authors.initials: NG
authors.lastname: Shah
authors.forename: T I
authors.initials: TI
authors.lastname: Trivedi
authors.forename: R A
authors.initials: RA
authors.lastname: Tankshali
authors.forename: J A
authors.initials: JA
authors.lastname: Goswami
authors.forename: J S
authors.initials: JS
authors.lastname: Shah
authors.forename: D H
authors.initials: DH
authors.lastname: Jetly
authors.forename: T P
authors.initials: TP
authors.lastname: Kobawala
authors.forename: K C
authors.initials: KC
authors.lastname: Patel
authors.forename: S N
authors.initials: SN
authors.lastname: Shukla
authors.forename: P M
authors.initials: PM
authors.lastname: Shah
authors.forename: R J
authors.initials: RJ
authors.lastname: Verma
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000032:analysis; D002294:Carcinoma, Squamous Cell / Q000473:pathology*; D002471:Cell Transformation, Neoplastic; D018450:Disease Progression; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D009061:Mouth Mucosa / Q000166:cytology / Q000473:pathology*; D009062:Mouth Neoplasms / Q000473:pathology*; D011237:Predictive Value of Tests; D012016:Reference Values; D014059:Tongue / Q000473:pathology; D014062:Tongue Neoplasms / Q000473:pathology
chemical_list: D014408:Biomarkers, Tumor